Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Pridopidine hydrochloride by Prilenia Therapeutics Development for Huntington Disease: Likelihood of Approval
Pridopidine hydrochloride is under clinical development by Prilenia Therapeutics Development and currently in Phase III for Huntington Disease. According to...
Pridopidine hydrochloride by Prilenia Therapeutics Development for Demyelinating Diseases: Likelihood of Approval
Pridopidine hydrochloride is under clinical development by Prilenia Therapeutics Development and currently in Phase I for Demyelinating Diseases. According to...
Pridopidine hydrochloride by Prilenia Therapeutics Development for Huntington Disease: Likelihood of Approval
Pridopidine hydrochloride is under clinical development by Prilenia Therapeutics Development and currently in Phase III for Huntington Disease. According to...